Asia-Pacific Neurological Disorder Drugs Market Size, Industry Trends, Share and Forecast 2020-2026

The Asia-Pacific neurological disorder drugs market is anticipated to grow significantly over the forecast period (2020-2026). China, India, and Japan, are the key economies contributing to the Asia-Pacific neurological disorder drugs industry growth. The key factors that primarily drive the market growth include the rising prevalence of neurological disorders and key contributions by the key players. 

Asia-Pacific has a potential market due to the increasing R&D and investments by big pharmaceutical companies in novel drug development and innovation. The rising elder population over 65 years of age is the prime factor that creates scope for the growth of the Asia-Pacific neurological disorder drugs market as this population pool is at high risk of developing neurological disorders such as Parkinson’s Disease, and Alzheimer’s Disease. 

To Request a Sample of our Report on Asia-Pacific Neurological Disorder Drugs Market: https://www.omrglobal.com/request-sample/asia-pacific-neurological-disorder-drugs-market

As per the World Bank 2019, Japan has around 28.0% geriatric population, China has 11.4%, Thailand has 12.4%, Singapore has 12.4%, while India has a total of 6.4% population aged 65 and over. As elder people are more prone to diseases, hence, creates a wide scope for the market growth in the region. 

Besides, the presence of the key players such as Cadila Healthcare Ltd., Astellas Pharma Ltd., and Cipla Ltd., among others are also contributing to the growth of the market. 

Market Coverage

·        Market number available for – 2019-2026

·        Base year- 2019

·        Forecast period- 2020-2026

·        Segment Covered- By Disorder Type

·        Region Covered- Asia-Pacific

·        Competitive Landscape- Cadila Healthcare Ltd., Astellas Pharma Ltd., Cipla Ltd., Sun Pharmaceuticals Industries ltd., Teva Pharmaceuticals Industries Ltd., and Takeda Pharmaceutical Co., Ltd. . 

Key questions addressed by the report

·        What is the market growth rate?

·        Which segment dominates the market in the base year?

·        Which segment will project the fastest growth in the market?

·        How COVID-19 impacted the market?

·        Recovery Timeline

·        Deviation from pre-COVID-19

·        Most affected segment

·        Who is the leader in the market?

·        How players are addressing challenges to sustain growth?

·        Where is the investment opportunity?

(Get 15% Discount on Buying this Report)

A full Report of Asia-Pacific Neurological Disorder Drugs Market is Available at: https://www.omrglobal.com/industry-reports/asia-pacific-neurological-disorder-drugs-market

Asia-Pacific Neurological Disorder Drugs Market – Segmentation

By Disorder Type

·        Epilepsy

·        Alzheimer’s Disease

·        Parkinson’s Disease

·        Multiple Sclerosis

·        Huntington Disease

·        Others

Asia-Pacific Neurological Disorder Drugs Market – Countries Covered 

·        China

·        India

·        Japan

Rest of Asia-Pacific

Company Profiles 

·        Alembic Pharmaceuticals Ltd.

·        Overview

·        Alembic Pharmaceuticals in Neurological Disorder Drug Landscape

·        Recent Developments

·        Astellas Pharma Inc.

·        AstraZeneca Plc

·        Cadila Healthcare Ltd.

·        Cipla Ltd.

·        Daiichi Sankyo Espha Co., Ltd.

·        Eisai Co. Ltd.

·        GlaxoSmithKline Plc

·        Novartis International AG

·        Otsuka Pharmaceutical Co., Ltd.

·        Pfizer Inc.

·        Rusan Pharma Ltd. 

·        Sun Pharmaceutical Industries Ltd.

·        Takeda Pharmaceutical Co., Ltd.

·        Teva Pharmaceutical Industries Ltd.

Reasons to buy from us –

1.  We cover more than 15 major industries, further segmented into more than 90 sectors.

2.  More than 120 countries are for analysis.

3.  Over 100+ paid data sources mined for investigation.

4.  Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/asia-pacific-neurological-disorder-drugs-market

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

Comments

Post a Comment

Popular posts from this blog

European Data Backup and Recovery Market Size, Share, Analysis, Industry Report and Forecast 2019-2025

  European Data Backup and Recovery Market are expected to reach $5.7 billion in 2027, growing at a CAGR of 9.5% during the forecast period (2021-2027). Factors responsible for the growth of the market in Europe are well-developed telecommunication infrastructure, high internet penetration, high adoption of cloud-based devices among people and organization. Regulations regarding the data localization such as GDPR by the European Union and countries own data localization and protection act are providing growth to the market. Major economies which are expected to hold a considerable market are UK, Germany, France, Italy, and Spain. These economies are part of the European Union, which covers most of the continent. The aim of the European Union was to increase economic cooperation and encourage free trade among countries. To Request a Sample of our Report on European Data Backup and Recovery Market :   https://www.omrglobal.com/request-sample/european-data-backup-recovery-...
Read more

Insect Repellent Market Is Likely to Experience a Tremendous Growth by 2031

This informative Insect Repellent Market report provides new method and covers foremost regions such as Latin America, Middle East, North America, Europe, Africa and Asia Pacific. Making most out of the consumer insights and market opportunities, market players can boost up the revenue rate of their business. It also permits key organizations to make communication with customers and know their demands for making right investment in the product development. By increasing the product portfolio by referring the important market data provided in this Insect Repellent Market research report, key players can grow and expand their business forward. Continuously developing customer demands are also described in this global report to help new entrants make required changes in the final product launch and then bring into the market. It becomes easy for key players to prioritize the demands and requirements of target audience and have complete understanding of end-user experience with the help o...
Read more

Asia-Pacific Urban Air Mobility Market Growth, Size, Share, Industry Report and Forecast 2019-2025

The Asia-Pacific urban air mobility market is estimated to grow at a CAGR of 12.6% during the forecast period. The Asia-Pacific urban air mobility market is segmented on the basis of component and operation. Based on the component, the market is further segmented into infrastructure and platform. The infrastructure segment is further segmented into charging stations, traffic management, and others whereas, the platform segment is further classified into air taxi, personal air vehicle, air ambulance, and others. The platform segment dominated the global urban air mobility market. To Request a Sample of our Report on Asia-Pacific Urban Air Mobility Market :   https://www.omrglobal.com/request-sample/asia-pacific-urban-air-mobility-market Asia-Pacific is home to several emerging economies and is seen as the potential market for the UAM owing to growing urbanization coupled with increasing traffic congestion and increasing high-income groups in the region. The growth of the As...
Read more